Example: Heart Attack
Clinical Trials on Adenosquamous Carcinoma of the Endometrium
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Alagille Syndrome
- Anemia Postoperative
- Chemonaive
- FGFR2 Gene Rearrangement
- HBV Carrier
- IV Injection
- Local Steroid Injection
- Multiple Myeloma in Relapse
- Polio
- Prognostic Factors
- Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)
- Renal Transplantation
- Tobacco Use Cessation
- View Full List
Sponsors and Collaborators
- 4Pharma Ltd.
- Andrew D Duckworth
- Chugai Pharma Taiwan
- Enzychem Lifesciences Corporation
- Inova Fairfax Hospital
- Liberty University
- M.S.T. Medical Surgery Technology LTD.
- Matthew Lunning, DO
- Southern Health NHS Foundation Trust
- St. Marianna University School of Medicine
- Städtisches Klinikum München GmbH
- Successful Hospital of Xiamen university
- Torsby sjukhus
- View Full List
Drug Interventions
- ACTIQ (Oral transmucosal fentanyl citrate)
- Anagliptin BID Treatment
- CR6086
- FEC Chemotherapy
- IV Gemcitabine
- Ibuprofen Placebo Tab
- Ketamine + Magnesium sulfate (drug combination)
- PF-299804 (Dacomitinib)
- Paravertebral Nerve Block
- Part 2, Cohort 1
- Propofol 10 Mg/mL Intravenous Emulsion
- Tacrobell capsule 1mg
- Trazodone HCl
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations